🆕 in OpenSource: Cardiology
Explanted hearts with amyloidosis continue beating, oftentimes for up to 30 minutes after they are removed.
In this Imaging Pearl, @BrettSperryMD and Jessica Heimes describe a patient with AL cardiac amyloidosis who had achieved complete hematologic response within 3 months on cyclophosphamide, bortezomib, dexamethasone and daratumumab. End-stage heart failure symptoms and recurrent pleural effusions persisted, and he underwent heart transplantation.
A typical explanted heart with a dilated cardiomyopathy has minimal or no agonal contractions and quickly becomes soft and pliable. Amyloid hearts permanently retain their native three-dimensional shape because of extensive fibrosis and amyloid fibril infiltration in all cardiac chambers. With their high ventricular mass, agonal contractions can be noted for quite some time after explant.
Early diagnosis of cardiac amyloidosis is essential to avoid these irreversible structural changes.
https://t.co/52lLgfDL88
Free to read, no paywalls
@cardiac_md The program will be paid through $100 million in sales taxes, imagine how much impact you could have if you spent it on heart healthy communities that would benefit everyone, not just those lucky enough to get screened
Macrotroponin, a troponin-IgG complex, can result in longer circulation times and lead to a "false positive" assay, risk associated with macrotroponin in this small study appears to be similar to a normal population (TnI < 5 ng/L) https://t.co/iP4l2y9o0s
South Asians have a disproportionate risk of CVD, one feature is the combination of high trigs, low HDL, high apoB, with relatively normal LDL. CTCA may be warranted to address risk not captured in common risk scoring systems. @JACCJournals https://t.co/aBTDayhhjr
Women's powerlifting legend Jan Todd talking about the history of the sport and being the first woman (of only 28 ever) to lift the 700-lb Dinnie Stones https://t.co/uGKuDrlPEn @99piorg
"Veterans enrolled in high-veteran MA plans were more likely to have inpatient CVD care financed by the VA, suggesting that MA plans may be shifting costs despite receiving capitated payments intended for inpatient care." https://t.co/VkagONYkla editorial by @JeremySussman
My take home would be that asking patients about cannabis use, smoked or otherwise, is worthwhile for patients with and at risk for CVD to counsel on the possible risks. https://t.co/6exmsrtqqc
Systematic review of cannabis and CV health out in JAHA, some highlights: even if cannabis products are not smoked, "one pivotal mechanism that links cannabis to atherosclerosis is endothelial cell dysfunction and impaired NO production.", driven by CB1 receptor activation
Subgroup analysis of @VeteransHealth participants in the COURAGE trial, with median 15 years followup (25 yrs max), no difference in death/MI with invasive over conservative mgmt of stable CAD @JAMA_current https://t.co/YcV54qm0Y2
Thanks to our @NJACC sister chapter the Hellenic Society of Cardiology for inviting me to speak on the Role of PET in detecting Ischemia in Women during joint session with @ACCinTouch. An honor sharing the stage w/ ACC President @Drroxmehran@demanddeborah@MyASNC@PanithayaC
Summarizing a hospitalization is a task that can be incredibly time consuming, is exceptionally valuable for adequate followup, and receives essentially zero reimbursement incentive to do well, if AI can do it as well as a human, sounds good. https://t.co/BBV63P1mkw
Long term followup in ISCHEMIA-CKD, high rates of mortality, but not different between invasive and conservative mgmt (57.4% v 56.8%, HR 1.05 [95% CI, 0.87–1.28) with median f/u 8 yrs https://t.co/vDK3FipD51